Gabapentin drug misuse signals: A pharmacovigilance assessment using the FDA adverse event reporting system.
Sign Up to like & getrecommendations! Published in 2019 at "Drug and alcohol dependence"
DOI: 10.1016/j.drugalcdep.2019.107709
Abstract: BACKGROUND Although there have been increasing reports of intentional gabapentin misuse, epidemiological evidence for the phenomenon is limited. The purpose of this study was to determine whether there are pharmacovigilance abuse signals for gabapentin. METHODS… read more here.
Keywords: reporting; drug; using fda; pharmacovigilance ... See more keywords
Comparison of safety of lecanemab and aducanumab: a real-world disproportionality analysis using the FDA adverse event reporting system
Sign Up to like & getrecommendations! Published in 2025 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2025.1593989
Abstract: Objective Studies on anti-Aβ drugs for the treatment of Alzheimer’s disease (AD) have garnered significant attention; however, their safety still requires further research and monitoring. Although recent studies have analyzed the adverse drug events (ADEs)… read more here.
Keywords: aducanumab; system; reporting; fda adverse ... See more keywords